These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5973379)

  • 21. [Immunity to poliomyelitis virus in Costa Rica].
    Pelon W; Villarejos VM; Gamboa F; Zeledón F; Jiménez R; Fallas M
    Bol Oficina Sanit Panam; 1966 Sep; 61(3):229-36. PubMed ID: 4224634
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mali children antipoliomyelitic immunity before and after two oral immunizations against poliomyelitis (author's transl)].
    Fofana Y; Ehrengut W; Koch I; Allerdist H; Diallo D
    Med Trop (Mars); 1981; 41(2):151-5. PubMed ID: 7242300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Status of immunity to poliomyelitis in various population groups. II].
    Nardi G; Bellelli E; Tanzi ML; Bracchi U; Monaci V; Corsello A
    Ann Sclavo; 1971; 13(5):553-66. PubMed ID: 5153400
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 28. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A serological evaluation of an immunization programme in Salt Cay, Turks, and Caicos Islands.
    Morgan P; Koplan JP; Miller GJ; Hull B; Ashcroft MT; Rosenberg M
    West Indian Med J; 1981 Jun; 30(2):68-71. PubMed ID: 7257341
    [No Abstract]   [Full Text] [Related]  

  • 30. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavior of complement-fixing antibodies against poliomyelitis in an infantile community of Milan].
    Braga A
    Ann Sclavo; 1971; 13(3):343-52. PubMed ID: 5153361
    [No Abstract]   [Full Text] [Related]  

  • 33. [On 2 cases of kerato-iritis and iritis appearing during oral anti-poliomyelitis vaccination].
    Guffanti A; Laverone F
    Ann Ottalmol Clin Ocul; 1966 Oct; 92(10):821-6. PubMed ID: 5997177
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination against poliomyelitis using oral vaccine.
    O'Regan JB
    J Ir Med Assoc; 1967 Mar; 60(357):84-5. PubMed ID: 6020586
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).
    Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G
    Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In favor of a practical plan of social protection against poliomyelitis].
    Petrilli FL; Crovari P
    Minerva Med; 1967 Aug; 58(61):2698-724. PubMed ID: 6049062
    [No Abstract]   [Full Text] [Related]  

  • 40. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.